Thursday, July 3, 2025 7/3/2025

Coordination of PAR and Ub signaling in mitochondria

Award Number: R35GM149339
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2023
PERIOD OF PERFORMANCE END DATE: 03/31/2028

Group Awards By:

View Award Description

Coordination of PAR and Ub signaling in mitochondria - Project Summary/Abstract Over the past 10 years, our research program has aimed at discovering molecular mechanisms that control metabolic adaptation in response to nutrient availability, cellular differentiation, and oxidative stress through genomic reprogramming. With NIGMS support, we have made significant contributions to identifying mechanisms responsible for the coordinated regulation of gene transcription and translation during the Mitochondrial Stress Response (MSR). Our work has identified a key role for non-degradative ubiquitination in both processes, showing that the regulated shuttling of GPS2 – an endogenous inhibitor of K63 ubiquitination – between mitochondria and nucleus is an essential strategy for maintaining mitochondrial homeostasis. As a complement to these mechanistic studies, we also investigated – in projects supported by NIDDK and the Department of Defense – the physiological relevance and translational potential GPS2-mediated regulation of ubiquitin signaling in breast cancer and obesity-associated disorders. Together, these studies have revealed the importance of GPS2-mediated restriction of K63Ub signaling in promoting metabolic adaptation and mitochondria remodeling during stress and cellular differentiation. This large body of work highlights our expertise in the field and our unique position to further investigate the crosstalk between this newly identified pathway and other PTMs involved in regulating mitochondrial function. In particular, we will focus our future studies on the crosstalk between ubiquitination and ADP-ribosylation. These PTMs work in tandem in the regulation of nuclear genome stability, innate immunity and stress-induced translational regulation. However, their relationship in regulating mitochondrial function has not yet been investigated. In fact, although the presence of ADP-ribosylation activity in mitochondria was known for decades, the identity of the mitochondrial ART enzyme/s has been elusive, hindering more detailed studies on the role and regulation of mitochondrial proteins through ADP-ribosylation. As we recently identified NEURL4 as a mitochondria-dedicated ADP-ribosyl transferase under the regulation of stress-induced and GPS2-mediated reprogramming, we are now in the position of carrying those studies. We propose a research plan spanning two major areas:1) Investigating the spatial and functional regulation of mitochondria retrograde signaling in response to mitochondrial stress and 2) Exploring the crosstalk between ubiquitination and ADP-ribosylation in regulating mitochondrial homeostasis. Our research plan addresses three key problems: i) the spatial regulation of mitochondria retrograde signaling; ii) the functional contribution of mitochondria retrograde signaling to the regulation of ADP-ribosylation and ubiquitination across subcellular compartments; iii) the molecular mechanisms underlying the coordinated regulation of ADP-ribosylation/ ubiquitination. Successful completion of the proposed studies will lead to a better understanding of the mechanisms regulating mitochondria homeostasis through post-translational modifications and possibly reveal regulatory strategies to be targeted for therapeutic purposes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $439,725 )
2025	2025	TRUSTEES OF BOSTON UNIVERSITY	85 EAST NEWTON ST # M-921	BOSTON	MA	02118	SUFFOLK	USA	Biomedical Research and Research Training	001	3	4/24/2025	NON-COMPETING CONTINUATION	$439,725
2025	2024	TRUSTEES OF BOSTON UNIVERSITY	85 EAST NEWTON ST # M-921	BOSTON	MA	02118	SUFFOLK	USA	Biomedical Research and Research Training	000	2	11/5/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $439,725

Issue Date FY: 2024 ( Subtotal = $439,725 )
2024	2024	TRUSTEES OF BOSTON UNIVERSITY	85 EAST NEWTON ST # M-921	BOSTON	MA	02118	SUFFOLK	USA	Biomedical Research and Research Training	000	2	3/5/2024	NON-COMPETING CONTINUATION	$395,753
2024	2024	TRUSTEES OF BOSTON UNIVERSITY	85 EAST NEWTON ST # M-921	BOSTON	MA	02118	SUFFOLK	USA	Biomedical Research and Research Training	001	2	6/17/2024	NON-COMPETING CONTINUATION	$43,972
														Subtotal = $439,725

Issue Date FY: 2023 ( Subtotal = $431,356 )
2023	2023	TRUSTEES OF BOSTON UNIVERSITY	85 E NEWTON ST M-921	BOSTON	MA	02118	SUFFOLK	USA	Biomedical Research and Research Training	000	1	3/10/2023	NEW	$431,356
														Subtotal = $431,356

Grand Total All Awards = $1,310,806

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Coordination of PAR and Ub signaling in mitochondria

Award Number: R35GM149339

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2023

PERIOD OF PERFORMANCE END DATE: 03/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer